Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP338183.RABR1gfl4b-EG_p2J0t8gp6ZmUlm6rlDEAaSweVK3oQjU130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338183.RABR1gfl4b-EG_p2J0t8gp6ZmUlm6rlDEAaSweVK3oQjU130_provenance.
• NP338036.RAe_ynQnn-DgeudQllDe-I0wpZyhcgmVUxVKPS7UGmNcs130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338036.RAe_ynQnn-DgeudQllDe-I0wpZyhcgmVUxVKPS7UGmNcs130_provenance.
• NP1105911.RABtw9D_SL2w6hVVyehuKib9T_M8Q_ZvwcIGpjtl53Qa4130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105911.RABtw9D_SL2w6hVVyehuKib9T_M8Q_ZvwcIGpjtl53Qa4130_provenance.
• NP621754.RAUFL22gDCTgWih8eXkYIgTFNgylZ8c1_HW7eYJFIE5lk130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621754.RAUFL22gDCTgWih8eXkYIgTFNgylZ8c1_HW7eYJFIE5lk130_provenance.
• NP625449.RAdodVA8kP9JLGZv8DwXAscorQTnQJ17UV49K1Inna87Q130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625449.RAdodVA8kP9JLGZv8DwXAscorQTnQJ17UV49K1Inna87Q130_provenance.
• NP624309.RA8eI-jJrquewYz6J7OW8BGEVDuWpO0CLEs2BEDpf0kuI130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624309.RA8eI-jJrquewYz6J7OW8BGEVDuWpO0CLEs2BEDpf0kuI130_provenance.
• NP622993.RA3zmkQt9GO5KEx4cEbgHtvePbGYTR9o1id4RI3rYDKKA130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622993.RA3zmkQt9GO5KEx4cEbgHtvePbGYTR9o1id4RI3rYDKKA130_provenance.
• assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.
• NP829430.RAYF0oSkh8xKtHdz9Xot4lugs7ypINVk-yP9Rjf48V7ko130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829430.RAYF0oSkh8xKtHdz9Xot4lugs7ypINVk-yP9Rjf48V7ko130_provenance.
• NP1105907.RA0V2FgRv3biSMoV_sXcxxbv6WFVrsp5XJbBlZgMn5Qt0130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105907.RA0V2FgRv3biSMoV_sXcxxbv6WFVrsp5XJbBlZgMn5Qt0130_provenance.
• NP1105909.RA3gvGyWJ-p1OIRP4M-WQIlnC_jwHCr6qFL8eIgUfwHi4130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105909.RA3gvGyWJ-p1OIRP4M-WQIlnC_jwHCr6qFL8eIgUfwHi4130_provenance.
• assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1105905.RAOFDrICwVWT7mhfCsisBj8BGSOLqmEpSesmnLXHs6rtA130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105905.RAOFDrICwVWT7mhfCsisBj8BGSOLqmEpSesmnLXHs6rtA130_provenance.
• NP1105908.RAG4l1BxpstCdTbHZPDOVhoA2Yzp16lbX03lUOJ6ZSh2Q130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105908.RAG4l1BxpstCdTbHZPDOVhoA2Yzp16lbX03lUOJ6ZSh2Q130_provenance.
• NP1105906.RAk0eWUVax1T9Ykdy46xchA8A5IzhIrsrW07wsC6ruLmY130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105906.RAk0eWUVax1T9Ykdy46xchA8A5IzhIrsrW07wsC6ruLmY130_provenance.